MedTrace Logo

PJ-011726 IntelliSpace Cognition MCI Study

NCT04243642 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 117

Last updated 2022-07-18

No results posted yet for this study

Summary

This study aims to create a reference database of digital cognitive assessment data in combination with neuroimaging data of patients with mild cognitive impairment. The investigators will explore and derive correlations between parameters from routine MRI images and brain volumetric analysis and the digital cognitive data to identify parameters that are relevant to classify MCI patients vs preexisting healthy control data.

Conditions

  • MCI
  • Cognitive Function 1, Social

Interventions

DEVICE

IntelliSpace Cognition

Philips IntelliSpace Cognition (ISC) is a digital assessment platform that supports Healthcare Professionals (HCP) in assessing the cognition of individuals. It consists of two interfaces connected to the DCDx-module in the cloud. ISC is hosted on the Philips Health Suite Digital Platform (HSDP). The first interface is the patient's interface and is presented via a tablet to collect data on how the patient performs a series of tests. The second interface is the clinician's interface and can be used on any PC or tablet. It allows for assessments to be selected and administered, observations made, data analytics performed and the generation of a report.

Sponsors & Collaborators

  • Qserve

    collaborator INDUSTRY

  • Dent Neurologic Institute

    collaborator OTHER

  • Philips Electronics Nederland B.V. acting through Philips CTO organization

    lead INDUSTRY

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-30
Primary Completion
2022-04-14
Completion
2022-04-14
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04243642 on ClinicalTrials.gov